Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
The 1,600-square-foot research facility will serve as a training and development hub.
January 21, 2025
By: Charlie Sternberg
Sartorius and McMaster University have opened a new bioprocessing automation lab at the university’s Faculty of Engineering in Hamilton, Ontario.
The 1,600-square-foot research facility will serve as a training and development hub, where McMaster students and Sartorius employees will work with other industry partners to accelerate developments in bioprocess modeling, simulation and advanced control.
“The opening of the Sartorius Bioprocess Automation Lab marks a milestone in McMaster’s commitment to advancing biomanufacturing capabilities in Canada,” said Dr. Heather Sheardown, Dean of the Faculty of Engineering at McMaster University. “This generous contribution will support technological innovations in large-scale biotherapeutics manufacturing that enhance production efficiency and ultimately expand access to life-saving treatments for chronic illnesses such as autoimmune disorders and cancers.”
Prof. Dr. Oscar-Werner Reif, Chief Technology Officer of Sartorius, added, “This partnership enables McMaster University and Sartorius to explore and industrialize innovative bioprocessing solutions together with partners from the biopharmaceutical industry. In this state-of-the-art facility young researchers from academia and the industry will jointly develop innovative modeling and predictive control solutions that help to simplify and accelerate biomanufacturing processes – ultimately driving faster developments of improved therapies that will be accessible to patients around the world.”
The funding for the new facility comes via stage two of the Biosciences Research Infrastructure Fund (BRIF) competition, the centerpiece of a $2.2 billion CAD ($1.5 billion) national program developed to build a strong and resilient domestic biomanufacturing and life sciences sector. This makes it the first BRIF-funded facility to open in Canada.
Building on these contributions, a team of McMaster researchers has secured additional Alliance Grant funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) to launch an extensive four-year collaboration with Sartorius.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !